Abstract
Vaccinia virus has been used to express many diverse genes, such as prokaryotic enzymes, eukaryotic growth factors, protozoan structural proteins, and >50 different virus gene products (for reviews, seerefs. 1–3). The widespread use of vaccinia virus as a vector owes much to the ease of generating recombinants, the authenticity of the foreign gene product, and the wide variety of uses to which they have been put. For example, HIV 1 (human immunodeficiency virus) envelope glycoprotein expressed by a vaccinia recombinant is biologically and antigenically indistinguishable from the authentic glycoprotein (4–bi7). Recombinants have been used to generate HIV-neutralizing antibody (4–6) to immunize animals and humans (8–10), and to analyze cytotoxic T-cell and antibody-dependent cellular cytotoxicity (11–13). Furthermore, the antigenicity of HIV enuhas been improved by site-directed mutagenesis of protease cleavage sites (14).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mackett, M. and Smith, G. L. (1986) Vaccinia virus expression vectors. J Gen. viral. 67, 2067–2082.
Mackett, M., Smith, G. L., and Moss, B. (1985) The construction and characterisation of vaccinia virus recombmants expressing foreign genes, in DNA Cloning A Radical Approach (Clover, D. M., ed.), IRL, Oxford, pp. 191–211.
Moss, B. and Flexner, C. (1987) Vaccinia virus expression vectors. Annu. Rev. Immund. 5, 305–324.
Chakrabarti, S., RobertGuroff, M., Wong-Staal, F., Callow, R. C., and Moss, B. (1986) Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature 320, 535–537.
Hu, S.-L., Kosowski, S. G., and Dalrymple, J. M. (1986) Expression of AIDS virus envelope gene in recombinant vaccinia virus. Nature 320, 537–540.
Kieny, M. P., Rautmann, G., Schmitt, D., Dott, K, Wain-Hobson, S., Alizon,., Girard, M., Chamaret, S., Laurent, A., Montagnier,., and Leoocq, J.-P. (1986) AID virus env protein expressed from a recombinant vaccinia virus. Biotechnology 4, 790–795.
Lifson, J. D., Feinberg, M. B., Reyes, G. R, Rabm, L., Banapour, B., Chakmbarti, S., Moss, B., Wong-Staal, F., Steiner, K S., and Engleman, E. G. (1986) Induction of CD4-depen dent cell fusion by the HTLVIII/LAV envelope glycoprotein. Nature 323, 725–728.
Hu, S.-L., Fultz, P. N., McClure, H. M., Eichberg, J. W., Thomas, E. K., Zarling, J., Singhal, M. C., Kosowski, S. G., Swenson, R B., Anderson, D. C., and Todaro, G. (1987) Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature 328, 721–723.
Zagury, D., Leonard, R., Fouchard, M., Reveil, B., Bernard, J., Ittele, D., Cattan, A., Zirimwabagabo, L., KaLumbu, M., Justin, W., Salaun, J.-J., and Goussard, B. (1987) Immunization against AIDS in humans. Scientific correspondence. Nature 326, 249,250.
Zagury, D., Bernard, J., Chenier, R., Desportes, I., Leonard, R., Fouchard, M., Reveil, B., Ittele, D., Lurhuma, Z., Mbayo, K, Ware, J., Salaun, J.-J., Goussard, B., Dechazal, L., Burny, A., Nara, P., and Callow, R. C. (1988) A group specific anamnestic immune reaction against HIV 1 induced by a candidate vaccine against AIDS.Nature 332, 728–731.
Zarling, J. M., Eichberg, J. W., Moran, P. A., McClure, J., Sridhar, P., and Hu, S.-L. (1987) Proliferative and cytotoxic T-cells with AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. J Immunol. 139, 988–990.
Alker, B. D., Chakrabarti, S., Moss, B., Paradis, T.J., Flynn, T., Dumo, A. G., Blumberg, R. S., Kaplan, J. C., Hirsch, M. S., and Schooley, R. T. (1987) HIV-specific cytotoxic T-lymphocytes in seropositive individuals. Nature 328, 345–348.
alker, B. D., Flexner, C., Paradis, T.J., Fuller, T. C., Hirsch, M. S., Schooley, R. T., and Moss, B. (1988) HIV-l reverse transcriptase is a target for cytotoxic T-lymphocytes in infected individuals. Scrence 240, 64–66.
Keiny, M. P., Lathe, R., Riviere, X., Dott, K, Schmitt, P., Cirard, M., Montagnier, L., and Lecocq, J.-P. (1988) Improved antigenicity of the HIV anu protein by cleavage site removal. Protein Eng. 2, 219–225.
Moss, B. (1985) Replication of poxviruses, in Virology (Fields, B. N., Knipe, D. M., Chanock, R. M., Melnick, J. L., Roizman, B., and Shape, R. E., eds.), Raven, New York, pp. 658–703.
Boyle, D. B. and Coupar, B. E. H. (1988) A dominant selectable marker for the construction of recombinant poxviruses. Cene65, 123–128.
Falkner, E. G. and Moss, B. (1988) Eschericia colic gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J viral. 62, 1849–1854.
Chakrabarti, S., Brechling, K., and Moss, B. (1985) Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques, Mol. Cdl.Biol. 5, 3403–3409.
ackett, M., Smith, G. L., and Moss, B. (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Viral. 49, 857–864.
ilson, E. M., Hodges, W. M., and Hruby, D. E. (1986)Construction of recombinant vaccinia virus strains using single-stranded DNA insertion vectors. Gene 49, 207–213.
Stunnenberg, H. G., Lange, H., Philipson, L., van Miltenburg, R. T., and Van der Vliet, P. C. (1988) High expression of functional adenovirus DNA polymerase and precursor terminal protein using recombinant vaccinia virus. Nuc& Acids Res. 16, 2431–2444.
uerst, T. T., Earl, P. L., and Moss, B. (1987) Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. MoL Cell. Biol. 7, 2538–2544.
Coupar, B. E. H., Andrew, M. E., Both, G. W., and Boyle, D. B. (1986) Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur.J. Immud. 16, 1479–1487.
Rohrmann, G., Yuen, L., and Moss, B. (1986) Transcription of vaccinia virus early genes by enzymes isolated from vaccinia virions terminates downstream of a regulatory sequence. (Cell 46, 1029–1035.
Browne, H. M., Churcher, M.J., Stanley, M. A., Smith, G. L., and Minson, A. C. (1988) Analysis of the Ll gene product of human papilloma virus type 16 by expression in a vaccinia virus recombinant. J Gen. ViiL 69, 1268–1273.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 The Humana Press Inc., Clifton, NJ
About this protocol
Cite this protocol
Mackett, M. (1991). Manipulation of Vaccinia Virus Vectors. In: Murray, E.J. (eds) Gene Transfer and Expression Protocols. Methods in Molecular Biology, vol 7. Humana Press. https://doi.org/10.1385/0-89603-178-0:129
Download citation
DOI: https://doi.org/10.1385/0-89603-178-0:129
Publisher Name: Humana Press
Print ISBN: 978-0-89603-178-4
Online ISBN: 978-1-59259-494-8
eBook Packages: Springer Protocols